[1]
2026. Development and Validation of the Accelerated Inflammatory-Metabolic Index (AIMI): A Composite Biomarker for Biochemical Assessment of Obesity-Associated Cardiometabolic Dysfunction. Medical Forum Monthly. 37, 8 (Sep. 2026). DOI:https://doi.org/10.60110/medforum.370808.